The Startup Building Edible Insulation to Tackle a 1.4 Gigaton CO2 Problem

Heating and cooling account for roughly 40% of global energy‑related CO₂ emissions, yet a large share of that heat is lost through inadequate insulation. Nanoplume’s bio‑aerogel tackles this inefficiency by mimicking the ultra‑light structure of NASA‑grade aerogels while replacing hazardous silica with biodegradable polymers. The result is a material that not only triples thermal resistance but also reduces thickness by more than half, directly addressing the 60% energy waste identified in current building envelopes.

The technology’s differentiators extend beyond performance. By leveraging a low‑cost, bio‑based manufacturing process, Nanoplume achieves a production cost roughly 75% lower than legacy aerogels, making large‑scale deployment financially viable. Its edibility and non‑toxicity eliminate health concerns, allowing architects and engineers to specify the material without additional safety protocols. This safety narrative, reinforced by founder Theresa Hoffmann’s on‑stage tasting, builds trust and simplifies regulatory approval across both construction and food‑related logistics sectors.

Market timing further amplifies Nanoplume’s appeal. The cold‑chain industry, valued at $34 billion, suffers from high energy consumption for temperature control, presenting an immediate revenue stream for the startup. Success there can fund expansion into the $1.4 gigaton CO₂‑heavy building insulation market, unlocking multi‑billion‑dollar opportunities. For angel investors, the venture combines climate impact, strong IP derived from NASA research, and SEIS‑eligible tax relief, positioning it as a compelling high‑growth, high‑return prospect.